Canada: Competition Bureau Releases Follow-Up Report On Generic Drug Competition

On November 25, 2008, the Competition Bureau released its second report, Benefiting from Generic Drug Competition in Canada: The Way Forward, on the competitive framework for generic drugs in Canada. In her speech announcing the report, the Commissioner of Competition characterized it as "a timely prescription for change". The objective of the report was to examine and recommend ways for Canadians to obtain the full benefits of generic drug competition. In addition to providing an update on generic drug pricing and the development of public and private plans in Canada, the Bureau's report includes specific recommendations for public and private plans.

Benefiting from Generic Drug Competition in Canada: The Way Forward

In the report, the Competition Bureau concludes that Canadians could save up to $800 million a year if private plans and provinces change the way they pay for generic drugs to reflect the competitive prices of those drugs. The Bureau predicts that potential savings could increase to more than $1 billion per year in coming years as several brand name drugs lose patent protection.

The report is a follow-up to the Bureau's October 2007 Generic Drug Sector Study which was initiated in response to research that determined that the price of generics was higher in Canada than in other countries. In the 2007 study, the Bureau concluded that while there was strong competition in the supply for many generic drugs, the benefits of competition were not being reflected in the prices provincial governments, private plan reimbursers and consumers paid for them.

Recommendations for Public Plans

The report indicates that public plans account for 48% of drug expenditures in Canada. While noting that some provinces have taken action on generic drug pricing (Ontario and Quebec in particular), the Bureau estimates that further savings of up to $200 million are available.

To maximize the benefits from generic competition, the report recommends that public plans consider putting the following "key elements" in place:

  • Mechanisms to obtain competitive generic drug prices. Measures such as introducing competitive tendering, drug price monitoring or sequential formulary listing could be used as a basis for reimbursing pharmacies for the competitive cost of their drugs.
  • Separate reimbursement of pharmacy services from reimbursement for generic drugs. While recognizing the view that generic drug rebates have offset under-funding of dispensing services, and that they support the provision of other pharmacy services (such as dispensing and patient counselling), the report finds that direct remuneration for these services based on their supply, rather than generic drug rebates, would allow public money to be directed more effectively.
  • Incentives for generic drugs, where they are lower-priced, to be dispensed in place of their interchangeable brand products. The report notes that it is important to maintain incentives for pharmacies to dispense low cost generic drugs and promote a high level of generic substitution.
  • Coordination of actions by individual provinces to avoid unintended anti-competitive effects. Provinces should consider the effects their policies can have on other jurisdictions and the competitive supply of generic drugs across the country. It is interesting to note that the report acknowledges that some practices adopted independently by provinces, such as "most-favoured-nation" policies and competitive tendering for formulary listing, may have anti-competitive effects on other provinces depending on how they are implemented. However, the report also states that obtaining benefits from competitive generic drug prices for public plans does not require a national approach.

Recommendations for Private Plans

According to the report, private payers (businesses, employees and out-of-pocket individuals) have the greatest potential for savings. Private payers account for 52% of generic drug expenditures in Canada and the report concludes that private payers could potentially save up to $600 million per year.

Although not specific in its recommendations, the report finds that governments can assist private payers by ensuring that there are no unnecessary legislative, regulatory or professional barriers to the development of innovative private sector approaches.

The report also finds that, unlike in the U.S., private plans have a limited impact on generic drug pricing. U.S. private sector plan providers obtain rebates or discounts from manufacturers and pharmacies for generic drugs; the report discusses the potential adoption of similar strategies in Canada. These potentially controversial strategies include the following:

  • Establishing preferred pharmacy networks. Under this model, pharmacies compete to belong to networks of pharmacies typically by offering discounts on wholesale prices to plan providers in order to increase prescription numbers. Plan providers then negotiate generic drug product reimbursement prices with member pharmacies. Differences between the reimbursement price and the pharmacy cost for the drugs are retained by the pharmacy.
  • Promoting greater use of mail order pharmacies. The report notes that mail order dispensing in Canada has been limited compared to the U.S. and suggests that mail order pharmacies may be a competitive alternative for repeat order customers.
  • Providing patients with incentives to seek lower prices. The report cites U.S. examples of plan members being encouraged to obtain their drugs through preferred provider networks to avoid or reduce co-payments.

The report also notes that individual plan members and persons paying out of pocket can play a key role by comparing prices and services when shopping for drugs.


In announcing the report, the Commissioner advocated that money saved through improved generic drug competition would be available to be reinvested in the health-care system or passed on to those who pay the bills. Some examples referenced in her speech include allowing drug plans to maintain or enhance coverage, reducing premiums and direct funding of some pharmacist services.

Generic drugs compete in complex, dynamic distribution systems, governed by a patchwork of regulations across Canada. As a result, the Competition Bureau's report will no doubt generate some controversy among stakeholders. It is clear from the report and the Commissioner's recent comments that health-related markets will continue to be an area of ongoing Bureau enforcement and advocacy activity.

Click here for a copy of the report and links to the Commissioner's comments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.